These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 31208104

  • 1. Levamisole in Children with Idiopathic Nephrotic Syndrome: Clinical Efficacy and Pathophysiological Aspects.
    Mühlig AK, Lee JY, Kemper MJ, Kronbichler A, Yang JW, Lee JM, Shin JI, Oh J.
    J Clin Med; 2019 Jun 16; 8(6):. PubMed ID: 31208104
    [Abstract] [Full Text] [Related]

  • 2. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
    Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM.
    Cochrane Database Syst Rev; 2020 Apr 16; 4(4):CD002290. PubMed ID: 32297308
    [Abstract] [Full Text] [Related]

  • 3. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
    Pravitsitthikul N, Willis NS, Hodson EM, Craig JC.
    Cochrane Database Syst Rev; 2013 Oct 29; (10):CD002290. PubMed ID: 24166716
    [Abstract] [Full Text] [Related]

  • 4. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N, Kim S, Craig J, Hodson E.
    Arch Dis Child; 2016 Apr 29; 101(4):404-8. PubMed ID: 26289063
    [Abstract] [Full Text] [Related]

  • 5. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
    BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
    [Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
    Sharma S, Kalra S, Shukla S, Sharma P.
    Nephrology (Carlton); 2022 Sep 01; 27(9):758-762. PubMed ID: 35619554
    [Abstract] [Full Text] [Related]

  • 7. New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome.
    van Husen M, Kemper MJ.
    Pediatr Nephrol; 2011 Jun 01; 26(6):881-92. PubMed ID: 21229269
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A.
    Kidney Int; 2019 Jan 01; 95(1):210-218. PubMed ID: 30497684
    [Abstract] [Full Text] [Related]

  • 9. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
    Basu B, Babu BG, Mahapatra TK.
    Clin Exp Nephrol; 2017 Feb 01; 21(1):143-151. PubMed ID: 27108294
    [Abstract] [Full Text] [Related]

  • 10. [The treatment with levamisole of frequently recurring steroid-sensitive idiopathic nephrotic syndrome in children].
    Kemper MJ, Amon O, Timmermann K, Altrogge H, Müller-Wiefel DE.
    Dtsch Med Wochenschr; 1998 Feb 27; 123(9):239-43. PubMed ID: 9524533
    [Abstract] [Full Text] [Related]

  • 11. Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.
    Basu B, Preussler S, Sander A, Mahapatra TKS, Schaefer F.
    BMC Nephrol; 2020 Nov 30; 21(1):520. PubMed ID: 33256621
    [Abstract] [Full Text] [Related]

  • 12. Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience.
    Kuźma-Mroczkowska E, Skrzypczyk P, Pańczyk-Tomaszewska M.
    Cent Eur J Immunol; 2016 Nov 30; 41(3):243-247. PubMed ID: 27833440
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
    Ekambaram S, Mahalingam V, Nageswaran P, Udani A, Geminiganesan S, Priyadarshini S.
    Indian Pediatr; 2014 May 30; 51(5):371-3. PubMed ID: 24953577
    [Abstract] [Full Text] [Related]

  • 14. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
    Iran J Kidney Dis; 2010 Oct 30; 4(4):292-6. PubMed ID: 20852369
    [Abstract] [Full Text] [Related]

  • 15. Second-line options for refractory steroid-sensitive and -resistant nephrotic syndrome.
    Oh J, Kemper MJ.
    Expert Rev Clin Pharmacol; 2010 Jul 30; 3(4):527-37. PubMed ID: 22111681
    [Abstract] [Full Text] [Related]

  • 16. Experience with second line drugs in frequently relapsing and steroid dependent childhood nephrotic syndrome in a large Saudi center.
    Alsaran K, Mirza K, Al-Talhi A, Al-Kanani E.
    Int J Pediatr Adolesc Med; 2017 Jun 30; 4(2):66-70. PubMed ID: 30805504
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials.
    Tan L, Li S, Yang H, Zou Q, Wan J, Li Q.
    Medicine (Baltimore); 2019 May 30; 98(22):e15927. PubMed ID: 31145359
    [Abstract] [Full Text] [Related]

  • 18. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
    Gruppen MP, Bouts AH, Jansen-van der Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC, all members of the Levamisole Study Group.
    Kidney Int; 2018 Feb 30; 93(2):510-518. PubMed ID: 29054532
    [Abstract] [Full Text] [Related]

  • 19. Levamisole in relapsing steroid-sensitive nephrotic syndrome: where do we stand?
    Kemper MJ, Neuhaus TJ.
    Kidney Int; 2018 Feb 30; 93(2):310-313. PubMed ID: 29389398
    [Abstract] [Full Text] [Related]

  • 20. An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome.
    Sinha A, Devi KG, Kalra S, Mani K, Hari P, Bagga A.
    Kidney Int; 2024 May 30; 105(5):1113-1123. PubMed ID: 38360110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.